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Abstract:  We  performed  epi-mode  pump-probe  imaging  of  melanin  in 
excised human pigmented lesions and both hemoglobin and melanin in live 
xenograft  mouse  melanoma  models  to  depths  greater  than  100  µm. 
Eumelanin  and  pheomelanin  images,  which  have  been  previously 
demonstrated to differentiate melanoma from benign lesions, were acquired 
at the dermal-epidermal junction with cellular resolution and modest optical 
powers (down to 15 mW). We imaged dermal microvasculature with the 
same  wavelengths,  allowing  simultaneous  acquisition  of  melanin, 
hemoglobin  and  multiphoton  autofluorescence  images.  Molecular  pump-
probe  imaging  of  melanocytes,  skin  structure  and  microvessels  allows 
comprehensive, non-invasive characterization of pigmented lesions. 
©2011 Optical Society of America 
OCIS codes: (170.3880) Medical and biological imaging; (180.5810) Scanning microscopy; 
(320.7150) Ultrafast spectroscopy. 
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1. Introduction 
Early detection of melanoma is critical to a positive patient outcome, but remains clinically 
challenging. The current gold standard is excision of the lesion followed by histopathology, 
but this is not an effective screening method and leads to unnecessary patient trauma and 
increased  medical costs. Optical imaging  has had good success in noninvasively  studying 
disease through the use of fluorescence, Raman and absorptive signatures [1–5]. Multiphoton 
imaging gives microscopic images with cellular resolution and depth selectivity in tissues 
such  as  the  skin,  and  is  therefore  a  promising  technology  for  studying  and  screening 
melanoma. 
Many imaging techniques have been applied to the problem of melanoma. Reflectance 
confocal microscopy gives good structural images based on reflective and refractive features 
in  skin,  such  as  melanosomes  and  keratin  [6,7].  However,  it  lacks  molecular  specificity. 
Photoacoustic  microscopy  is  a  powerful  technique  with  excellent  penetration  depth  for 
imaging intrinsic absorbers, such as hemoglobin and melanin [8–10]. Vasculature of all size 
scales  and  its  oxygenation  state  makes  an  excellent  target  for  this  method,  as  do  any 
chromophores  which  can  be  discriminated  based  on  their  linear  absorbance.  However, 
chemical varieties of melanin have very similar absorption spectra and therefore cannot be 
separated by photoacoustic microscopy. Similarly, pigmented lesions can be imaged using the 
autofluorescence of proteins and melanin, but this has no specific contrast for disease [11]. 
Two-color  pump-probe  imaging  by  modulation  transfer  is  a  versatile  technique  for 
creating  contrast  based  on  a  wide  range  of  molecules  and  nonlinear  processes,  providing 
highly  specific  and  functional  images  of  biological  and  medical  samples.  Pump-probe 
imaging  has  the  optical  sectioning  and  scattering  resistance  properties  of  multiphoton 
microscopy but does not rely on the generation of new wavelengths of light, which previously 
limited  the  array  of  possible  imaging  targets.  Contrast  can  be  based  on  sum-frequency 
absorption, excited state absorption, ground state depletion or stimulated emission. Fu et al. 
developed pump-probe imaging of melanin, oxy- and deoxyhemoglobin and acquired in vivo 
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stimulated emission [14]. 
Two intrinsic chromophores are relevant to the disease state of melanoma: hemoglobin 
and  melanin.  Hemoglobin  can  be  used  to  track  new  blood  vessel  formation  and  tissue 
hypoxia, features that both correlate with malignancy [15,16]. Melanin contains information 
about the location, morphology and biochemical state of melanocytes [17,18]. In human skin, 
two kinds of melanins are found: eumelanin and pheomelanin. Eumelanin is a brown-black 
pigment and serves a photoprotective role. Pheomelanin is reddish-yellow, found in higher 
concentrations  in  red-haired  individuals,  and  acts  as  a  photosensitizer  when  exposed  to 
ultraviolet radiation [19,20]. Recently we demonstrated that pump-probe imaging can separate 
eumelanin and pheomelanin [21]. We investigated excised samples from human pigmented 
lesions  and  found  eumelanin  content  was  substantially  increased  in  melanoma  and  that 
imaging the microscopic distribution of eumelanin and pheomelanin could be used to separate 
melanomas  from  benign  nevi  in  a  highly  sensitive  manner  [22].  Previously  Fu  et  al. 
performed  epi-mode  imaging  on  the  surface  of  densely  pigmented  humans  hairs. 
Improvements in microscope design and signal collection now allow epi-mode imaging at 
physiologically  relevant  depths  in  scattering  tissue.  Imaging  at  depth  in  tissue  a  more 
challenging  target  because  imaging  takes  place  through  a  turbid  medium  and  we  rely  on 
backscattered probe light for detection, which decreases exponentially with depth [23]. We 
report epi-mode eumelanin / pheomelanin contrast and microvessel imaging in excised human 
pigmented  lesions  and  noninvasively  in  animal  models  for  melanoma,  extending  this 
technique  toward  optical  biopsy  as  well  as  for  fundamental  research  into  the  growth  and 
evolution of melanoma. 
Hybrid xenograft mouse systems were chosen for investigation because they offered the 
most accurate representation of melanoma in human skin. Mouse genetic models have been 
fruitful  in  understanding  the  genetic  mechanisms  mediating  melanoma  pathogenesis. 
However, there are major structural differences between mouse and human skin tissues, which 
make it difficult to faithfully and non-invasively perform longitudinal studies on the evolution 
of melanoma lesions in animal models [24]. To better mimic the tissue environment of human 
melanomas,  we  generated  a  xenograft  melanoma  model  on  immunodeficient  mice  with  a 
mixture of human epidermal cells and human melanoma cells [25]. The regenerated human 
skin was then monitored by noninvasive pump-probe imaging for melanoma progression. 
2. Experimental setup 
2.1. Pump-probe imaging by modulation transfer 
Pump-probe imaging was carried out in a similar fashion to the method outlined by Fu et al. 
[26].  A  titanium:sapphire  mode-locked  laser  operating  at  80  MHz  and  tuned  to  810  nm 
(Tsunami, Spectra-Physics) synchronously pumped an optical parametric oscillator containing 
a fan-poled crystal (Mira-OPO, Coherent). The signal wavelength was intracavity doubled to 
720 nm, which was modulated at 2 MHz with an acousto-optic modulator for use as the pump 
beam. The 810 nm beam was left unmodulated for use as the probe beam. A mechanical delay 
stage allowed control of the interpulse delay, and the two beams were combined on a dichroic 
mirror  and  directed  into  a  custom  constructed  scanning  laser  microscope.  A  polarizing 
beamsplitting cube was placed between the tube lens and the objective, oriented to pass both 
beams. Light was focused into the sample with a 20X air coupled 0.7 numerical aperture 
objective (Olympus). Pulse durations  were typically ~180 femtoseconds at the  sample, as 
measured by cross-correlation. Probe light backscattered by the sample was collected by the 
excitation objective in epi-mode. A portion of the backscattered light, which has a randomized 
polarization, was reflected by a polarizing beamsplitting cube after the objective. Two-photon 
excited autofluorescence was separated from backscattered probe light with a dichroic mirror 
and focused onto a photomultiplier tube (Hamamatsu). Probe light was passed through two 
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photodiode  (PDA55,  Thorlabs).  A  2.5  MHz  low  pass  filter  (Minicircuits)  removed  high 
frequency  noise  from  the  photodiode.  The  pump-probe  modulation  transfer  signal  was 
measured by a lock-in amplifier (SR844, Stanford Research Systems) tuned to the modulation 
frequency. A reference sample of rhodamine 6G was used to set the phase based on a known 
instantaneous  absorptive  signal.  Images  typically  were  acquired  at  13  seconds  per  frame, 
limited by the time constant of the lock-in amplifier. Eumelanin / pheomelanin contrast was 
based on the time delay behavior at each pixel, which was sampled by imaging at 17 separate 
interpulse delays. 
2.2. Ex vivo tissue samples 
Human pigmented lesions were excised and imaged fresh, without fixation or treatment. After 
imaging,  lesion  type  was  determined  by  a  dermatopathologist  examining  H&E  stained 
sections. All human studies were carried out with approval by the institutional review board 
for clinical investigations. 
2.3. Xenograft mouse model 
To  demonstrate  pump-probe  imaging  in  vivo,  we  acquired  pump-probe  images  of  a 
developing  melanoma  in  human  skin  grafted  mice  following  the  method  outlined  by 
Chudnovsky et al. [25]. The grafts were prepared as follows: a mixture of primary human 
keratinocytes and human melanoma cells (A2058) were seeded in a 10:1 ratio onto pieces 
(around 1 cm
2) of devitalized human dermis, which were kept in culture for 3-4 days until 
cells  reached  confluence  on  and  around  the  dermis.  These  regenerated  skin  tissues  were 
xenotransplanted onto SCID mice and then imaged with our pump-probe microscope. The 
graft  was  implanted  on  the  dorsal  skin  (back)  of  the  animal.  For  imaging,  mice  were 
anesthetized  with isoflurane and  mounted on  a custom  stage of an upright laser scanning 
microscope. A coverslip was clamped over the dorsal skin graft to immobilize the region, 
flatten  the  tissue  and  minimize  motion  artifacts.  The  noninvasive  nature  of  the  imaging 
procedure allowed the grafts to be followed over time. The Institutional Animal Care and Use 
Committee approved all procedures involving animal research. 
3. Results 
3.1. Melanin contrast in ex vivo human nevi 
We imaged an excised pigmented lesion pumping at 720 nm (15 mW) and probing at 810 nm 
(15 mW). Melanin in the skin was easily visible and structures as deep as 120 µm could be 
captured  (Fig.  1).  Pigmented  basal  cells  along  the  dermal-epidermal  junction  and 
keratinocytes in the superficial layers of the epidermis gave rise to strong signal. Below 20 
µm  into  the  tissue,  irregular  dermal  papillae  interdigitating  with  the  rete  ridges  of  the 
epidermis were visualized as a web-like pattern. The papillary dermis contained no melanized 
cells,  and  so  dermal  papillae  appeared  dark  (Fig.  1B,  arrowheads).  Keratinocytes  and 
melanocytes  along  the  dermal-epidermal  junction  were  heavily  pigmented  and  appeared 
bright. Pigmented basal cells were found at the base of rete ridges as deep as 120 µm from the 
surface (Fig. 1F, arrow). 
Examination of H&E sections taken from the excised lesion showed it to be a lentigo with 
hyperpigmentation  of  the  basal  layer  and  elongated  rete  ridges  (Fig.  1G).  No  nests  of 
melanocytes were found, and the number of melanocytes present in the basal layer was not 
larger  than  normal.  The  epidermis  was  roughly  20-40  µm  in  thickness.  Rete  ridges  were 
elongated to over 100 µm beneath the surface of the skin. No melanocytes or pigmented cells 
were  present  in  the  dermis.  Solar  damage  to  the  dermis  from  ultraviolet  radiation  (solar 
elastosis) was apparent. 
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Fig. 1. (A-F) Pump-probe epi-mode images of melanin at 0 fs interpulse delay in an excised 
lesion at 20, 40, 60, 80, 100 and 120 µm below the surface of the skin. At 40 µm deep (B), the 
dermal-epidermal  junction  was  clearly  imaged.  Epidermal  pigmented  cells  are  visible 
surrounding dermal  papillae  (arrowhead).  Rete  ridges  120  µm  below  the  surface  (F)  were 
observed (arrow). (G) H&E stained cross-section from the lesion showing the skin architecture, 
including dermal papilla (D.P.) and elongated rete ridges extending more than 100 µm below 
the surface. (H, I) 3D reconstructions of various regions from an excised lesion showing local 
details (Media 1) and a large area with clearly visible rete ridges encompassing the region 
imaged in Fig. 2. (Media 2). 
We  were  able  to  differentiate  pheomelanin  from  eumelanin  at  the  dermal-epidermal 
junction  with  modest  optical  power.  Pumping  with  5  mW  and  probing  with  10  mW,  we 
created maps of the melanin content along the dermal-epidermal junction with cellular detail 
(Fig. 2). A series of 17 images at different interpulse delays were acquired to sample the 
transient behavior of melanin. Principal component analysis was used to examine the different 
delay  traces  across  the  image  and  separate  the  transient  signals  of  eumelanin  from 
pheomelanin. Eumelanin has been shown to have an excited state absorption signal at these 
wavelengths,  while  pheomelanin’s  transient  behavior  is  described  mostly  by  ground  state 
depletion [21]. Melanin molecular contrast showed the excised lesion to have a generally 
uniform pigmentation. Most of the observed regions were pheomelanic. However, in one field 
of view a predominantly eumelanin-containing region was found (Fig. 2A, arrowhead), as 
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heterogeneous  pigmentation:  pheomelanic  on  average,  with  some  melanocytes  expressing 
eumelanin. 
 
Fig. 2. Melanin principal component epi-mode images showing chemical contrast of an excised 
lesion. Images were acquired with 5 mW pump power, 10 mW probe power. (A) Large field of 
view acquired 45 µm below the surface showing heavily pigmented rete ridges of relatively 
uniform  composition.  Arrowhead  denotes  a  eumelanic  region.  (B)  Smaller  field  of  view 
demonstrating cellular detail acquired 20 µm below the surface. Pigmented keratinocytes are 
resolved. 
3.2. Microvasculature in vivo imaging 
Hemoglobin can also be imaged via pump-probe at these wavelengths. Hemoglobin has a 
purely positive response (due to excited state absorption), while both melanins demonstrate a 
negative (bleaching) signal at 0 fs interpulse delay. Previously, Fu et al. demonstrated imaging 
the  in  vivo  oxygenation  state  of  microvasculature  in  transmission  mode  [26].  Using  our 
adapted setup, we have now imaged microvasculature greater than 100 µm below the surface 
of the skin in epi-mode (Fig. 3). We examined human skin grafts on our mouse melanoma 
model 4 weeks after implantation, after vascularization had taken place. Vasculature images 
were acquired at 0 fs interpulse delay using 19 mW pump power (720 nm) and 40 mW probe 
power  (810  nm).  3D  maps  of  capillaries,  venules  and  arterioles  can  be  simultaneously 
acquired with melanin images to provide a comprehensive picture of tissue function. 
3.3. Melanin molecular contrast in xenograft mice 
Figure 4 shows a pump-probe image of our mouse melanoma model containing significant 
chemical heterogeneity. Two weeks after implantation of the human skin graft, small dark 
spots appeared (Fig. 4A). Pump-probe imaging found melanin in all layers of the epidermis in 
one such spot, from the stratum corneum down to the dermal-epidermal junction 50-60 µm 
below the surface. Melanin was found in relatively pure deposits, with little mixing between 
eumelanin and pheomelanin. The center of the lesion was very pheomelanic, surrounded by a 
strongly eumelanic ring. Individual cells appeared to be uniformly pigmented. Fluorescence 
signals  measured  by  the  PMT  mostly  results  from  two-photon  excited  autofluorescence 
(TPEF) of NADH, elastin and keratin [1]. TPEF is most useful for orienting the melanin 
deposits and vessels in the skin, as keratin from corneocytes in the stratum corneum gives a 
very strong signal. This allows for accurate determination of the depth of the field of view, as 
well as orientation within the skin based on structural changes between the epidermis and 
dermis. 
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Fig. 3. In vivo epi-mode pump-probe images of mouse dermal microvasculature acquired 60, 
80, and 105 µm below the surface of the skin at 0 fs interpulse delay (A, B, C). Images were 
acquired with 19 mW pump and 40 mW probe power. Representative pump-probe delay traces 
at  these  wavelengths  for  eumelanin,  pheomelanin  and  hemoglobin  are  shown  (D  and  E). 
Hemoglobin is easily separated by its positive signal at time zero. (F) 3D reconstruction of the 
microvasculature (Media 3). 
 
Fig. 4. (A) A developing mouse melanoma, brightfield image. (B) In vivo epi-mode pump-
probe images with cellular detail acquired 45 µm below the surface of the skin (25 mW total 
power)  near  the  basal  layer.  Principal  component  images  are  co-registered  with  a 
simultaneously acquired TPEF image (blue). The central region of the tumor was pheomelanic 
(box 2), surrounded by a ring of eumelanin containing cells (box 1). (C) Time delay traces in 
each region show melanin’s characteristic transient behavior. 
4. Discussion and conclusion 
Important morphological features are captured by pump-probe imaging, including architecture 
of  the  epidermis,  location  and  organization  of  melanocytes  and  the  structure  of  the  local 
microvasculature. Histopathological markers for melanoma include presence of melanocytes 
in the epidermis (pagetoid spread), organization of melanocytes into nests, the presence of 
nests bridging rete ridges, enlarged melanocytes, confluent growth of melanocytes along the 
dermal-epidermal junction, and the presence of pigmented or immature melanocytes in the 
dermis [27]. Blood vessel architectural changes are also associated with tumor development: 
tumors will develop an angiogenic phenotype, producing more blood vessels with an irregular 
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these features can be captured by pump-probe imaging. 
More importantly, molecular contrast allows functional mapping of the lesion. We can 
investigate  the  behavior  of  melanocytes  by  examining  the  chemical  mixture  produced  by 
melanogenesis. It has been found that eumelanin content and the chemical heterogeneity of 
pigmentation allows differentiation between melanoma and benign lesions in biopsy samples. 
This information can now be acquired  in vivo. The oxygenation  state of blood vessels is 
relevant to tumor progression as well: Normal tissue will not have regions of severe hypoxia, 
but  many  tumors  will  have  chronically  and  transiently  hypoxic  regions.  Tumor  hypoxia 
correlates with a more malignant phenotype, resistance to treatments, increased metastasis and 
poor  outcomes  [16].  By  imaging  both  eumelanin/pheomelanin  distributions  as  well  as 
hemoglobin oxygenation, a full characterization of lesions can be made. 
We  have  demonstrated  the  viability  of  noninvasive,  epi-mode  pump-probe  imaging  of 
melanocytic  lesions.  Pump-probe  imaging  may  also  serve  as  the  basis  of  a  powerful 
diagnostic aid and screening tool for melanoma. Evaluating regions where biopsies are much 
more  difficult  to  obtain,  such  as  intraocular  melanoma,  or  where  tissue  conservation  is 
imperative, such as the face, could be very beneficial. This technique opens the door to a more 
detailed study and richer understanding of the progression of melanoma than has previously 
been possible. 
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